Earnings History Data for Evofem Biosciences, Inc. (EVFM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Evofem Biosciences, Inc.

Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-08-2022	AH	4:00 PM ET (Aug 4)	EVFM	Evofem Biosciences, Inc.	30.43	N/A	-1.08	-4.05	Evofem Biosciences reports Q2 results [8/4/2022 4:37 PM]	0.9434	0.05 (5.06%)	1.04	0.14 (15.81%)	0.28 - 14.61	32,320,024	14,010,000	5,536,016
Evofem Biosciences reports Q2 results [8/4/2022 4:37 PM] Evofem stock surges 27% as Phexxi sales pick up Q/Q, net loss narrows; affirms outlook [8/4/2022 6:46 PM] Evofem Biosciences Announces Strong Second Quarter 2022 Financial Results and Affirms 2022 Guidance [Aug-04-22 04:01PM] Evofem Biosciences Strengthens Board of Directors [Aug-03-22 08:24AM]
04-05-2022	AH	4:00 PM ET (May 4)	EVFM	Evofem Biosciences	32.00	N/A	-0.21	0.00	Evofem Biosciences reports Q1 results [5/4/2022 4:11 PM]	0.1106	-0.05 (-32.81%)	0.14	-0.02 (-14.82%)	0.11 - 1.42	15,607,437	4,260,000	904,016
Evofem Biosciences reports Q1 results [5/4/2022 4:11 PM] Evofem Biosciences plunges on announcing 1-for-15 reverse stock split [5/5/2022 9:22 AM] Evofem Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-04-22 04:01PM] Evofem Biosciences Announces 1-for-15 Reverse Stock Split [May-05-22 09:00AM]
03-03-2022	AH	4:00 PM ET (Mar 3)	EVFM	Evofem Biosciences, Inc.	79.52	-0.33	-0.22	-0.50	Evofem Biosciences GAAP EPS of -$0.33 misses by $0.10, revenue of $3.57M beats by $0.21M [3/3/2022 4:04 PM]	0.4387	-0.05 (-10.47%)	0.46	-0.04 (-7.14%)	0.36 - 3.77	3,585,193	2,910,000	84,415
Evofem Biosciences GAAP EPS of -$0.33 misses by $0.10, revenue of $3.57M beats by $0.21M [3/3/2022 4:04 PM] Evofem Biosciences declines 5% after bottom line earnings miss [3/4/2022 10:01 AM] Evofem Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update [Mar-03-22 04:00PM] Evofem Completes Enrollment in EVOGUARD Phase 3 Clinical Trial of EVO100 for Prevention of Chlamydia and Gonorrhea in Women [Mar-04-22 06:48AM]
15-11-2021	AH	4:25 PM ET (Nov 15)	EVFM	Evofem Biosciences, Inc.	102.56	-0.29	-0.30	-0.33	Evofem Biosciences EPS misses by $0.19, misses on revenue [11/15/2021 4:01 PM]	0.5580	-0.11 (-16.09%)	0.52	-0.15 (-22.11%)	0.51 - 5.53	12,520,158	2,760,000	991,985
Evofem Biosciences EPS misses by $0.19, misses on revenue [11/15/2021 4:01 PM] Evofem Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-15-21 04:00PM]
11-08-2021	AH	4:00 PM ET (Aug 11)	EVFM	Evofem Biosciences, Inc.	69.19	-0.27	-0.35	-0.39		0.7640	-0.08 (-9.68%)	0.82	-0.03 (-3.06%)	0.75 - 5.53	11,324,478	4,540,000	429,351
Evofem Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-11-21 04:27PM]
06-05-2021	AH	4:00 PM ET (May 6)	EVFM	Evofem Biosciences, Inc.	109.73	-0.56	-0.49	-0.40	Evofem Biosciences EPS misses by $0.07, misses on revenue [5/6/2021 4:07 PM]	1.22	0.0 (0.00%)	1.28	0.06 (4.92%)	1.21 - 6.87	7,363,112	4,530,000	234,697
Evofem Biosciences EPS misses by $0.07, misses on revenue [5/6/2021 4:07 PM] Evofem Biosciences, Inc. to Host Earnings Call [May-06-21 02:30PM] Evofem Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-06-21 04:01PM]
04-03-2021	AH	4:00 PM ET (Mar 4)	EVFM	Evofem Biosciences, Inc.	321.06	-0.50	-0.36	-0.27	Evofem Biosciences EPS misses by $0.14, misses on revenue [3/4/2021 4:01 PM]	2.26	-0.93 (-30.73%)	2.59	-0.68 (-20.80%)	1.91 - 6.87	14,579,949	3,181,469	674,882
Evofem shares down on Q4 miss, mixed-shelf offering [3/5/2021 8:58 AM] SIFY, WTI, OPEN and EVFM among notable midday movers [3/5/2021 12:36 PM] Why Evofem Biosciences Stock Is Falling Today [Mar-05-21 01:00PM]
09-11-2020	AH	4:05 PM ET (Nov 9)	EVFM	Evofem Biosciences, Inc.	201.58	-0.33	-0.44	-0.30	Evofem Biosciences EPS beats by $0.07, misses on revenue [11/9/2020 4:27 PM]	2.35	0.0 (0.21%)	2.39	0.05 (2.14%)	1.91 - 7.50	2,398,975	1,337,122	23,179

04-08-2020	PM	8:00 AM ET (Aug 4)	EVFM	Evofem Biosciences, Inc.	235.31	-0.39	-0.37	-0.35	Evofem Biosciences EPS misses by $0.54 [8/4/2020 8:05 AM]	3.08	-0.12 (-3.59%)	3.04	-0.16 (-5.00%)	2.73 - 7.50	3,877,623	2,776,199	892,153

06-05-2020	PM		EVFM	Evofem Biosciences, Inc.	259.38	-0.40	-0.33	-0.50	Evofem Biosciences EPS misses by $0.05 [5/6/2020 8:05 AM]	5.11	-0.12 (-2.20%)	4.98	-0.13 (-2.54%)	3.34 - 7.50	136,575	259,788	1,709